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By diversifying antibody biological effector functions, class switch DnA recombination has 
a central role in the maturation of the antibody response. Here we show that BCR-signalling 
synergizes with Toll-like receptor (TLR) signalling to induce class switch DnA recombination. 
BCR-signalling activates the non-canonical nF-κB pathway and enhances the TLR-dependent 
canonical  nF-κB  pathway,  thereby  inducing  activation-induced  cytidine  deaminase  (AID), 
which is critical for class switch DnA recombination. Escherichia coli lipopolysaccharide (LPs) 
triggers dual TLR4/BCR-signalling and induces hallmarks of BCR-signalling, including CD79a 
phosphorylation and Ca2 +  mobilization, and activates both the nF-κB pathways to induce AID 
and class switch DnA recombination in a PI(3)K p85α-dependent fashion. CD40-signalling 
activates  the  two  nF-κB  pathways  to  induce  AID  and  class  switch  DnA  recombination 
independent  of  BCR-signalling.  Finally,  dual  BCR/TLR-engaging  nP–lipopolysaccharide 
effectively elicits class-switched nP-specific IgG3 and IgG2b in mice. Thus, by integrating 
signals of the non-canonical and canonical nF-κB pathways, BCR and TLRs synergize to induce 
AID and T-cell-independent class switch DnA recombination. 
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I
nnate immune receptors recognize conserved microbe-associated   
molecular patterns and have important roles in the early stages 
of the immune response1. Toll-like receptors (TLRs) are a fam-
ily  of  conserved  innate  immune  receptors  highly  expressed  in 
macrophages, dendritic cells, epithelial cells and B cells2–4. Naïve 
B cells express a surface receptor for antigen (BCR) consisting of 
immunoglobulin (Ig)µ-chain (Igµ) and Igδ and react to antigens 
by making IgM and IgD antibodies (Abs). These are later diver-
sified  by  somatic  hypermutation  (SHM)  and  class  switch  DNA 
recombination (CSR)5. SHM provides the structural substrate for 
antigen-mediated selection of higher affinity antibody mutants by 
introducing point-mutations with rare deletions or insertions into 
rearranged Ig variable regions. CSR replaces the Ig heavy chain 
(IgH) constant (CH) region, for example, Cµ, with a downstream 
Cγ, Cα or Cε region, resulting in IgG, IgA or IgE antibodies with 
diverse biological effector functions6. Both SHM and CSR require 
activation-induced cytidine deaminase6 (AID), which deaminates 
deoxycytidine, leading to the emergence of deoxyuracil6. This is not 
germane to DNA and is dealt with by elements of the DNA repair 
machinery, eventually leading to insertion of point-mutations in 
variable Ig regions for SHM and double-strand DNA breaks (DSBs) 
in switch (S) regions6,7, which lie 5′ of each of CH regions (except 
for Cδ), for CSR.
CSR entails IgH locus germline IH-CH transcription, which is 
initiated by the IH promoter (Iµ, Iγ, Iα or Iε) and proceeds through 
the upstream and downstream S and CH regions engaged in the 
CSR process, giving rise to germline Iµ-Cµ, Iγ-Cγ, Iα-Cα or Iε-Cε  
transcripts6.  S  regions  contain  a  high  density  of  5′-AGCT-3′ 
repeats in their ‘core’ sequences. 5′-AGCT-3′ repeats recruit 14-3-3   
adaptor proteins, which, in turn, target AID to S region DNA to   
generate DSBs8. CSR then proceeds through deletion of the inter-
vening DNA and re-ligation of DSB free ends to form S–S junc-
tions.  The  post-recombination  sequences  are  transcribed,  giving 
rise to post-recombination Iµ-Cγ, Iµ-Cα or Iµ-Cε transcripts and 
‘mature’ VHDJH-Cγ, VHDJH-Cα or VHDJH-Cε transcripts for the 
IgG, IgA or IgE H chain6. The efficiency of CSR critically depends 
on the level of AID6,9, which is under tight transcriptional regula-
tion in a B-cell differentiation stage-specific fashion10, depending 
on HoxC4 (ref. 11), NF-κB (refs 11,12) and other transcription fac-
tors12–14. As shown by us11 and others12, the NF-κB p52 subunit (a 
hallmark of the non-canonical NF-κB pathway15) and p65 subunit 
(a hallmark of the canonical NF-κB pathway) bind to the AID gene 
(AICDA/Aicda) promoter and upstream enhancers, respectively.
AID and CSR are efficiently induced in T-dependent antibody 
responses by engagement of CD40 on B cells by surface CD154 
(CD40 ligand) expressed on CD4 +  T cells15 and in the presence of 
appropriate cytokines (for example, IL-4, TGF-β or IFN-γ). How-
ever, IgG and IgA Abs can arise early in viral and bacterial infec-
tions before T-cell help becomes available16, indicating that CSR 
can also unfold in a T-cell-independent fashion. Accordingly, mice 
deficient in T cells or CD154/CD40 can generate class-switched 
specific Abs that are protective against some bacterial or viral infec-
tions16,17. In addition, class-switched Abs arise against bacterial or 
viral antigens that elicit weak or no T-cell responses (T-independent 
antigens), such as bacterial polysaccharides and lipolysaccharides 
(LPS)18,19.  Further,  polysaccharide-specific  class-switched  IgG 
Abs, which are critical for protection against infections by capsular   
bacteria20, are decreased in about half of patients deficient in the 
TLR-signalling molecule MyD88 or IRAK4 despite normal levels of 
total IgG/IgA Abs21. Finally, TLR ligands, for example, TLR4 lig-
and lipid A and TLR9 ligand CpG, can significantly boost specific 
antibody responses to proteinic (T-dependent) antigens3,4,22 and, as 
such, are widely used as vaccine adjuvants.
Despite  the  putative  role  of  TLRs  in  class-switched  antibody 
responses, only few studies exist on CSR induction by TLR ligands, 
including TLR3 ligand poly(I:C)23, TLR7 ligand 8-mercaptoguanosine   
or loxoribine24 or CpG25. In these studies, TLR ligands alone trig-
gered  only  marginal  CSR,  if  at  all16,26,  suggesting  that  another   
B-cell-activating  stimulus  is  required  for  TLR-dependent  CSR 
induction. Indeed, engagement of selected surface B-cell molecules, 
such as CD38 (ref. 24), CD40 (ref. 25), CD180 (ref. 27), TACI (refs 
23,25,28) and IL-10R (ref. 25), has been suggested to enhance TLR-
dependent CSR. Likewise, TLR7- and TLR9-dependent CSR would 
be  enhanced  by  BCR  engagement24,25,29,  albeit  only  marginally 
(1–4% B-cell switching)24,25. The mechanisms underlying a puta-
tive BCR enhancement of TLR-triggered CSR are unknown, in spite 
of findings suggesting an integration of BCR- and TLR-signalling 
for activation of NF-κB30 and/or other transcription factors31–34. In 
contrast to other TLR ligands, LPS consists of a proper TLR-bind-
ing moiety (TLR4 ligand lipid A) and a repetitive polysaccharide 
moiety  (O-antigen).  This  can  elicit  specific  anti-polysaccharide 
antibody responses19 through mobilization of O-antigen-binding 
B cells35. However, in spite of wide and empirical usage of LPS in 
mouse B cells, the mechanism underlying LPS-dependent CSR and 
its enhancement by BCR crosslinking36 remain to be determined.
Here we have tested the hypothesis that BCR-signalling syner-
gizes with TLR-signalling for AID and CSR induction. We used a 
well-defined in vitro B-cell system to address the synergistic induc-
tion of CSR by BCR crosslinking18 and the agonistic ligand of each 
one of the five TLRs highly expressed in B cells, that is, surface 
TLR1 and TLR2 (which form TLR1/2 heterodimer) and TLR4, and   
endosomal TLR7 and TLR9 (ref. 37). We further addressed the 
molecular mechanisms, underlying the synergy of BCR and TLR 
in inducing AID and CSR, by measuring activation of central com-
ponents of the non-canonical and canonical NF-κB pathways and   
levels of AID expression, and by using B cells deficient in p85α 
(p85α–/–),  the  predominant  class  IA  regulatory  subunit  of  the 
PI(3)K lipid kinases that critically transduce BCR signals38. Finally, 
we analysed the unique properties of LPS in triggering dual BCR/
TLR-signalling and, therefore, activating both the non-canonical 
and canonical NF-κB pathways for induction of AID and CSR.
Results
BCR synergizes with TLRs to induce CSR. To test our hypothesis 
that  BCR  crosslinking  provides  a  B-cell-specific  signal  enabling 
TLRs to induce CSR, we analysed CSR in B cells stimulated with 
agonistic ligands of surface TLR1/2 and TLR4 and endosomal TLR7 
and TLR9. TLR1/2 ligand Pam3CSK4, TLR4 ligand lipid A, TLR7 
ligand R-848 or TLR9 ligand CpG showed various B-cell mitogenic 
activities and, in the presence of appropriate cytokines, all induced 
only marginal CSR to IgG1, IgG2a, IgG3, IgA and IgE, even at a 
tenfold higher dose than that typically used (Fig. 1; Supplementary 
Fig. S1). An agonistic anti-δ chain monoclonal Ab (mAb) conjugated 
to dextran (anti-δ mAb/dex), which crosslinks Igδ to trigger BCR-
signalling and induces limited B-cell proliferation but no CSR18, 
synergized with these TLR ligands to induce CSR in a potent and 
dose-dependent fashion, as shown by analysis of surface (s)Ig (Fig. 1;   
Supplementary  Fig.  S1),  germline  IH-CH,  circle  IH-Cµ,  post-
recombination Iµ-CH and mature VHDJH-CH transcripts (Fig. 2; 
Supplementary Fig. S2), and secreted Ig (Supplementary Fig. S3). 
Anti-δ mAb/dex synergized with TLR ligands to induce CSR but 
not by enhancing B-cell proliferation, as it increased switched B 
cells at each cell division and over a tenfold range of CpG or LPS 
concentrations (Fig. 1 and Fig. 2a,b), and increased circle Iγ1-Cµ 
transcripts, an accurate parameter of ongoing CSR (Fig. 2d). Anti-δ  
mAb/dex  did  not  further  enhance  CSR  induced  by  membrane 
CD154  (mCD154)  (Fig.  1b).  Unlike  anti-δ  mAb/dex,  BAFF  or 
APRIL only moderately enhanced TLR-dependent CSR to IgG1, 
despite  synergizing  with  anti-δ  mAb/dex  to  induce  CSR  to  IgA 
and, to a lesser extent, IgG1 (Supplementary Fig. S4). BCR and TLR 
synergy in CSR induction was further emphasized by a decrease in 
anti-δ mAb/dex and CpG-induced CSR by chloroquine, an inhibitor ARTICLE     
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of endosomal TLR maturation, and the negligible CSR induction by 
GpC, a weak TLR9 agonist39, and anti-δ mAb/dex (Supplementary 
Fig.  S5a).  Thus,  BCR  synergizes  with  TLR1/2,  TLR4,  TLR7  or 
TLR9 to induce efficient CSR; in the absence of BCR crosslinking, 
engagement of these TLRs alone results in only marginal CSR.
LPS induces BCR-signalling for CSR. LPS, unlike its lipid A moi-
ety, induced AID and CSR to all Ig isotypes (Fig. 1b; Supplementary   
Fig. S1 and ref. 6), suggesting LPS fulfills the requirement of dual 
BCR/TLR-signalling by engaging TLR4 through the lipid A moiety 
and BCR through the polysaccharidic moiety, respectively. In the 
normal B-cell repertoire, many B cells express BCRs that bind with 
variable  affinities  to  repetitive  polysaccharides35,  which  include 
the polysaccharidic moiety of LPS. Indeed, CD79a Tyr182, one of 
the two ITAM Tyr residues, which, on phosphorylation, transduce 
BCR-signalling29, was phosphorylated in B cells stimulated with 
anti-δ mAb/dex or anti-µ F(ab′)2 or LPS (within 3 h, and more 
within 24 h), but not lipid A (Fig. 3a). In addition, unlike anti-µ 
F(ab′)2, which induced a rapid increase of free cytosolic Ca2 +  ions 
([Ca2 + ]cytosol), anti-δ mAb/dex induced a slower, but continuous   
increase in [Ca2 + ]cytosol (Fig. 3b). As sustained extracellular Ca2 +  
entry is required upon BCR engagement for activation of Ca2 + -
dependent signalling pathways, we pretreated B cells with LPS, anti-
δ mAb/dex, lipid A or mCD154, followed by labelling with Ca2 +  
indicator dyes and then probing for Ca2 +  mobilization in response 
to anti-µ F(ab′)2. B cells, pretreated for 16 h with LPS or anti-δ 
mAb/dex, showed only a transient Ca2 +  flux on further stimula-
tion with anti-µ F(ab′)2, likely resulting from Ca2 +  release from ER 
stores only and without the sustained entry of Ca2 +  from the plasma 
membrane40, as it occurred in B cells that were pretreated with lipid 
A or mCD154 (Fig. 3c). This suggests that LPS or anti-δ mAb/dex 
likely triggered sustained Ca2 +  elevation before the B cells were 
rendered refractory to extra Ca2 +  entry. Finally, LPS-induced CSR 
could be further increased by anti-δ mAb/dex (Fig. 1b; Supplemen-
tary Fig. S1), which inhibited LPS-induced plasmacytoid differen-
tiation (Supplementary Fig. S5b), resulting in virtually no increase 
in secreted IgG1 or IgE (Supplementary Fig. S3). These experiments 
show that LPS triggers dual BCR/TLR-signalling by engaging TLR4 
through lipid A and by inducing CD79a Tyr phosphorylation and 
Ca2 +  mobilization (hallmark BCR-signalling events).
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Figure 1 | BCR crosslinking enables TLRs to induce efficient CSR. (a) Proportions of surface IgG1 +  (sIgG1 + ) B cells after stimulation of CFsE-labelled 
sIgδ +  B cells with TLR1/2 ligand Pam3CsK4, TLR4 ligand lipid A, TLR7 ligand R-848 or TLR9 ligand CpG at indicated doses, in the absence or presence of 
anti-δ mAb/dex at indicated doses, plus IL-4 (3 ng ml − 1). (b) Proportions of sIgG1 +  B cells at each cell division after stimulation of sIgδ +  B cells with LPs 
or mCD154 at indicated doses, in the absence or presence of anti-δ mAb/dex (100 ng ml − 1), plus IL-4 (3 ng ml − 1). (c) Proportions of sIgG1 +  B cells within 
each B cell division after stimulation of CFsE-labelled sIgδ +  B cells with Pam3CsK4 (100 ng ml − 1), lipid A (1 µg ml − 1), R-848 (30 ng ml − 1), CpG (1 µM), LPs 
(3 µg ml − 1) or mCD154 (1 u ml − 1), in the absence (teal) or presence (plum) of anti-δ mAb/dex (100 ng ml − 1), plus IL-4 (3 ng ml − 1). Data are representative 
of four independent experiments.ARTICLE
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BCR-signalling  increases  TLR-dependent  Aicda  expression. 
Consistent  with  its  potentiation  of  TLR-dependent  CSR,  anti-δ 
mAb/dex, which alone did not induce AID expression, significantly 
increased Aicda transcripts induced by TLR ligand Pam3CSK4, lipid 
A, R-848 or CpG (in the presence of IL-4), resulting in Aicda levels 
(peaking at 60 h) comparable to those induced by LPS (Fig. 4a,b). 
Anti-δ mAb/dex decreased mCD154 and IL-4-induced AID expres-
sion, consistent with its reduction of CD40-dependent CSR to IgG1   
(Fig. 1b). Anti-δ mAb/dex enhanced, to variable extents, germline 
Iγ1-Cγ1 transcription induced by IL-4 or IL-4 and TLR ligands 
(peaking as early as at 12 h) or mCD154. It also upregulated B-cell 
expression  of  PNA-binding  glycoproteins,  which  are  markers  of 
germinal centre B cells, as induced by CpG, but not CD40—high 
levels of PNA-binding glycoproteins induced by LPS were not fur-
ther increased by anti-δ mAb/dex (Fig. 4c; Supplementary Fig. S5c). 
Anti-δ  mAb/dex  downregulated  Blimp1  and  CD138  expression   
(Fig. 4a,d), consistent with inhibition of plasmacytoid differentia-
tion by BCR-signalling41. To further confirm that BCR-signalling 
increases TLR-dependent Aicda expression and CSR, we blocked 
BCR-signalling  with  an  anti-CD79a  mAb,  which  inhibited  LPS-
induced  CD79a  phosphorylation  (Fig.  3a).  This  blocking  anti-
CD79a mAb significantly reduced the levels of Aicda transcripts   
and inhibited CSR to IgG1, resulting in decreased levels of sIgG1 
and circle Iγ1-Cµ transcripts, as induced by the BCR/TLR dual 
engagement or LPS (Fig. 3d,e). Finally, that BCR signalling ena-
bled  TLR-dependent  CSR  by  upregulating  AID  expression  was 
demonstrated by the ability of exogenous AID to substitute anti-δ 
mAb/dex in TLR9-dependent CSR (Fig. 4e,f). Thus, BCR-signalling 
enables TLR-dependent induction of efficient CSR by enhancing 
TLR-dependent AID induction. It also enhances TLR-dependent 
expression of PNA-binding glycoproteins and suppresses plasma-
cytoid differentiation.
BCR and TLR activate both NF-κB pathways for AID induction. 
We next addressed the mechanisms underlying the synergy of BCR 
and TLRs in inducing AID expression, which is regulated by the 
HoxC4 and NF-κB transcription factors11,12. Anti-δ mAb/dex did 
not enhance TLR-induced expression of HoxC4, prompting us to 
hypothesize that BCR and TLRs synergize to induce AID by acti-
vating both the canonical NF-κB (p65) and non-canonical NF-κB 
(p52) pathways, as CD40 does15. To test this hypothesis, we tracked 
the kinetics of IκBα phosphorylation at Ser32 and p65 phosphor-
ylation at Ser536 (canonical) and expression of p100, the precursor 
of p52, and processing of p100 to p52 (non-canonical) in B cells 
stimulated with TLR ligands, anti-δ mAb/dex, or both (all in the 
presence of IL-4). Consistent with the findings that TLRs activate 
the canonical NF-κB pathway2, CpG or lipid A induced IκBα and 
p65 phosphorylation that did not peak until 40 m after stimulation. 
These phosphorylation events were accelerated and enhanced by 
anti-δ mAb/dex, as were IκBα and p65 phosphorylation induced by 
LPS, but not CD40 (Fig. 5; Supplementary Fig. S6). Anti-δ mAb/dex 
alone, however, did not activate appreciable p65 phosphorylation 
(Supplementary  Fig.  S6a).  Rather,  it  increased  the  level  of  both 
p52 and p100 within 24–48 h, the time frame of AID induction, as 
mCD154 did (Fig. 6a; Supplementary Fig. S7a). Like anti-δ mAb/
dex, LPS increased the levels of p100 and p52. Lipid A, or CpG, 
mainly increased p100, thereby providing more substrate for anti-δ  
mAb/dex-processing to p52 (Fig. 6a). Thus, BCR and TLRs each 
activates only one NF-κB pathway (non-canonical and canonical,   
respectively),  but  reciprocally  enhance  the  main  pathway  of   
activation by the other receptor, thereby synergizing in inducing 
AID expression, as mediated by both NF-κB pathways.
NF-κB activation by BCR/TLR engagement requires PI(3)K. As 
PI(3)K transduces BCR-signalling38, we next used p85α–/– B cells to 
explore the impact of impaired BCR-signalling on activation of the 
two NF-κB pathways and, therefore, TLR-dependent AID expres-
sion and CSR. Mature p85α–/– B cells expressed normal sIgδ levels38 
and, on stimulation with mCD154, showed normal proliferation and 
slightly higher levels of CSR than their p85α + / +  counterparts, likely 
owing to impairment in the tonic BCR-signalling that would have 
decreased CD40-dependent CSR (Fig. 7). In addition, anti-δ mAb/
dex did not affect CD40-dependent CSR in p85α–/– B cells (Fig. 7; 
Supplementary Fig. S8). On stimulation with Pam3CSK4, lipid A,   
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R-848 or CpG, p85α–/– B cells underwent limited CSR, as their 
p85α + / +  counterparts did. This and the comparable proliferation of 
TLR ligand-stimulated p85α–/– and p85α + / +  B cells demonstrated 
that p85α was not instrumental in transducing TLR-signalling in B 
cells. Anti-δ mAb/dex potentiation of TLR-dependent CSR, how-
ever, was impaired in p85α–/– B cells, even after normalization to 
cell division—the residual CSR likely resulted from BCR-signalling   
mediated  by  minor  PI(3)K  regulatory  subunits38  (Fig.  7a,b;  
Supplementary  Fig.  S8).  LPS-induced  CSR  was  also  impaired 
in  p85α–/–  B  cells,  consistent  with  an  important  role  of  BCR- 
signalling in this process. The decrease in dual BCR/TLR engage-
ment or LPS-induced CSR to IgG1 in p85α–/– B cells was associ-
ated with significantly reduced Aicda, germline (Iγ1-Cγ1), circle   
(Iγ1-Cµ) and post-recombination (Iµ-Cγ1) transcripts (Fig. 7c).
We further analysed the role of p85α-mediated BCR-signalling 
in activating the non-canonical NF-κB pathway. In p85α–/– B cells, 
in which BCR-signalling was defective whereas TLR- and CD40- 
signalling  were  intact,  anti-δ  mAb/dex-  or  LPS-induced  p100   
expression  and  processing  to  p52  were  virtually  abolished,  but   
lipid  A  or  CpG-induced  p100  expression  was  normal,  as  was 
mCD154-induced p100 expression and processing to p52 (Fig. 6b; 
Supplementary Fig. S7b). In addition, in these B cells, anti-δ mAb/
dex enhancement of lipid A- or CpG-induced (canonical NF-κB) 
p65 phosphorylation was impaired, as was LPS-induced p65 phos-
phorylation (Fig. 5; Supplementary Fig. S6b); CpG- or mCD154-
induced  p65  phosphorylation,  however,  was  largely  unaffected. 
Thus, through PI(3)K, BCR-signalling activates the non-canonical   
NF-κB  pathway  and  enhances  the  TLR-dependent  canonical   
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NF-κB pathway, thereby synergizing with TLRs in inducing AID 
and CSR.
BCR/TLR-engaging NP–LPS induces switched NP-specific IgGs. 
We next extended our in vitro findings to show that dual BCR/TLR 
engagement  induces  efficient  CSR  in  vivo  by  injecting  normal 
C57BL/6 mice with NP–LPS conjugate. This avoids proteinic linkages 
(such as in streptavidin used for conjugation to biotinylated moieties) 
that would introduce a T-cell-dependent component in the antibody 
response, thereby complicating the interpretation of results. The NP–
LPS conjugate would also maximize the number of B cells hit with 
concomitant (NP-specific) BCR-crosslinking and TLR4-engagement, 
as the frequency of B cells expressing NP-specific BCR in the normal 
mouse B cell repertoire is only ~10–7 (in our in vitro cultures, virtu-
ally all B cells were BCR-crosslinked by anti-δ mAb/dex). The pres-
ence of a large proportion of B cells expressing BCRs binding to the 
LPS polysaccharidic moiety was irrelevant, because such BCRs do not 
cross-react with NP. As predicted, NP–LPS induced a strong class-
switched (IgG3 and IgG2b, and to a lesser extent IgG1 and IgG2a) 
NP-specific antibody response, which was readily detectable 6 days 
after injection and sustained through day 12 (Supplementary Fig. S9).   
By  contrast,  a  comparable  class-switched  NP-specific  antibody 
response was not elicited by NP26 (which efficiently crosslinks NP-
specific BCRs but does not engage TLRs), or LPS alone. NP-binding 
to IgMs were detectable not only in mice injected with NP–LPS, but 
also and, to a lesser extent, in mice injected with NP26, likely owing to 
the decavalency and high avidity of this Ig class. Thus, these experi-
ments show that, as predicted by our in vitro findings, dual BCR/TLR 
engagement in vivo induces class-switched and specific antibodies. 
The IgG subclasses (IgG3 and IgG2b) elicited by NP–LPS reflect those 
characteristically induced by LPS6.
Discussion
Here we have shown that BCR-signalling synergized with TLR1/2-, 
TLR4-, TLR7- or TLR9-signalling to induce AID and enable CSR. 
Either signalling alone resulted in marginal (TLRs) or no (BCR) 
CSR. Importantly, BCR crosslinking synergized with all TLR lig-
ands analysed for CSR induction, thereby emphasizing the critical 
role of dual BCR/TLR-signalling in inducing specific and isotype-
diverse  antibodies  at  early  stages  of  the  response  to  bacteria  or 
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presence (plum) of anti-δ mAb/dex (all in the presence of 3 ng ml − 1 of IL-4, mean and s.e.m. of data from three independent experiments, P values: t-test). 
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viruses,  before  T-cell  help  becomes  available3,4.  In  addition,  as 
emphasized by our in vivo demonstration that NP–LPS conjugate 
elicited a strong NP-specific IgG3 and IgG2b response, CSR induced 
by dual BCR/TLR engagement underpins the generation of class-
switched Abs throughout T-independent responses, such as those 
involving  bacterial  or  viral  BCR-crosslinking  antigens,  together 
with TLR-engaging microbe-associated molecular patterns, such as 
LPS, Pam3CSK4, single-stranded RNA, polymerized flagellin, dou-
ble-stranded RNA or unmethylated microbial DNA. The important 
role of B-cell TLRs in antibody responses to microbial pathogens 
is emphasized by reduced IgGs, particularly against pyogenic bac-
teria,  in  patients  with  defective  TLR-signalling  pathways21  and 
decreased IgGs to protein antigens admixed with TLR ligands in 
TLR-, MyD88- and/or TRIF-deficient mice3,4.
BCR and TLR synergy in inducing AID and CSR reflects the acti-
vation by these two receptors of the non-canonical and canonical 
NF-κB pathways. As we showed here, TLR ligands activated NF-κB 
in B cells only through the canonical pathway2. This was potentiated 
by BCR crosslinking30 (particularly by anti-δ mAb/dex, which initi-
ates sustained BCR-signalling18,42), which also activated the non-
canonical NF-κB pathway. BCR and TLRs reciprocally enhanced the 
main NF-κB pathway activated by the other receptor; integration of 
the two signalling pathways would occur at the level of p100 induc-
tion (non-canonical) and TRAF6 activation (canonical), leading to 
induction of p52 and p65, respectively (Fig. 8). NF-κB p52 and p65 
subunits, which are also induced by CD154 and, as we showed here, 
LPS, bind to the AICDA/Aicda promoter and enhancer elements, 
respectively, to upregulate AID gene expression.
Impairment of BCR-signalling, as in p85α–/– B cells, virtually 
abolished the generation of p52 following stimulation with anti-δ  
mAb/dex  or  LPS,  thereby  decreasing  AID  expression  and  CSR. 
This,  together  with  the  largely  normal  phosphorylation  of  p65 
(despite  a  slight  decrease  in  IκBα  phosphorylation)  in  p85α–/–  
B cells and virtually no difference in proliferation and (limited) CSR 
between p85α–/– and p85α + / +  B cells on stimulation by CpG plus 
IL-4, strongly suggests that PI(3)K-signalling is more important for 
transducing BCR-signalling, than TLR-signalling, in B cells. The 
same time-dependence of p52 and AID induction, both of which 
progressively increased within 48 h and were perhaps linked to cell 
divisions, further emphasizes the critical role of the non-canonical 
NF-κB pathway in AID and CSR induction. Accordingly, unlike 
anti-δ  mAb/dex,  soluble/monomeric  anti-Ig  Abs  cannot  exten-
sively crosslink BCR to initiate sustained signalling for activation 
of the non-canonical NF-κB pathway43 or enhancement of AID 
and CSR44,45. Finally, BCR signalling, while upregulating AID and   
CSR  and  PNA-binding  glycoproteins,  downregulated  Blimp1 
and  CD138,  suggesting  that  antigen  engagement  of  BCR  delays   
plasmacytoid differentiation of TLR-stimulated B cells until CSR 
completion.
We showed that BCR and TLRs synergized to induce CSR by 
enhancing AID expression rather than by merely promoting B-cell 
proliferation or survival. We also showed that BCR-enhanced and   
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Figure 5 | BCR crosslinking enhances the TLR-dependent canonical NF-B pathway in a p85-dependent fashion. (a–c) Levels of phosphorylated 
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independent experiments.ARTICLE
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IL-4-dependent  germline  Iγ1-Cγ1  transcription  peaked  earlier 
than Aicda expression, thereby suggesting a synergy of the (BCR- 
activated)  non-canonical  NF-κB  pathway,  with  the  (IL-4R- 
activated) JAK-Stat6 pathway, to induce rapid gene expression. BCR 
enhancement  of  cytokine  (IL-4,  IFNγ  and/or  TGFβ)-promoted 
germline IH-CH transcription and TLR-dependent AID induction 
would  underpin  T-cell-independent  CSR  induction.  Also,  anti-δ 
mAb/dex, together with LPS, which induced B cells to undergo CSR 
to IgG3, induced high levels of post-translational modifications of 
histones in the Sγ3 DNA region46; modified histones would stabilize 
14-3-3 binding to S regions to unfold CSR8.
The requirement for dual BCR/TLR engagement to induce effi-
cient CSR can be fully satisfied by LPS alone. As we have shown, 
LPS, but not lipid A, induced CD79a phosphorylation (a unique 
hallmark of signalling emanating from BCR, but not from other 
receptors) and Ca2 +  mobilization, and activated the non-canonical   
NF-κB  pathway,  indicating  that  the  LPS  polysaccharidic  moiety   
triggers  BCR-signalling,  which  synergizes  with  lipid  A  moiety-
engaged  TLR4-signalling  to  induce  AID  expression  and  CSR. 
Indeed, blocking CD79a or deficiency in PI(3)K p85α hampered 
induction of CSR by LPS in the same fashion as it hampered induc-
tion of CSR by TLR ligands plus anti-δ mAb/dex. Findings that mice 
deficient in PI(3)K display negligible serum IgG3 and that B cells 
deficient in BCR-signalling elements, such as CD19, Btk, Blnk, Lyn 
or Vav, show greatly reduced responses to LPS47–51 further support 
our  conclusion  that  LPS  activates  BCR-signalling  in  addition  to 
TLR4-signalling for CSR. The ability of O-antigen to bind (specific) 
BCRs to induce antibody responses to LPS in vivo19 also provides 
strong support for the argument that the LPS polysaccharidic moi-
ety engages the BCR and synergizes with the lipid A-engaged TLR4 
to induce efficient CSR; polysaccharides have not been reported to 
interact with receptors on B cells other than the BCR35.
Like dual BCR/TLR-signalling, including that triggered by LPS, 
CD40-signalling activates the two (non-canonical and canonical) 
NF-κB  pathways  for  AID  induction,  demonstrating  that  T-cell-
independent and T-cell-dependent CSR, despite their significant 
difference in the nature of triggering stimuli, entail the same set 
of transcription factors critical for AID induction (Fig. 8). CD40, 
however,  employs  different  signal  transducers,  utilizing  TRAFs 
(TRAF2/TRAF3, in particular) to activate both NF-κB pathways 
and induce AID and CSR52—TRAF2 and TRAF3 have no role in 
the BCR-signalling pathway, thereby explaining the lack of synergy 
of BCR and CD40 in CSR. That CD40 activation of NF-κB and 
induction of AID and CSR were not impaired in p85α–/– B cells 
is  also  consistent  with  findings  that  BCR/PI(3)K-signalling  has 
no significant role, or possibly even a negative role through Akt- 
mediated  phosphorylation  and,  therefore,  nuclear  exclusion  of 
Foxo1 (a transcription factor shown to enhance Aicda expression in 
CD40-dependent CSR53); BCR-signalling, however, is required for 
CD40-dependent SHM54. BCR-triggered and time-dependent acti-
vation of the non-canonical NF-κB pathway versus nuclear exclu-
sion of Foxo1 might influence the outcome of CD40-dependent   
CSR. Also, consistent with the dependence of IgA switching on 
TACI, which activates the canonical NF-κB pathway55, anti-δ mAb/
dex synergized with TACI ligand BAFF or APRIL to induce CSR to 
IgA (our findings and ref. 28).
Our findings that dual BCR/TLR engagement induced CSR in, 
up to, 40% of B cells indicate that T-cell-independent CSR can be 
as efficient as CD40-dependent CSR, as induced by specific CD4 +  
T-helper cells. They also provide much needed evidence for the 
argument  that  dual  BCR/TLR  engagement  is  highly  relevant  to 
T-independent antibody responses, a notion further supported by 
our in vivo experiments showing a strong NP-specific IgG response 
induced by NP–LPS, which is devoid of any proteinic component 
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and, therefore, would not elicit T-cell help. In spite of (conflicting) 
suggestions on the ability of NP26 (NP-Ficoll) to induce modest lev-
els of class-switched antibodies (for example, refs 56,57), our exper-
iments have clearly shown that NP26 could not induce an in vivo 
class-switched NP-specific antibody response comparable to that 
induced by NP–LPS, further extending our in vitro findings that 
BCR crosslinking alone did not efficiently induce AID or CSR.
Collectively, our in vitro and in vivo findings indicate that among 
the pool of B cells that can be activated by TLR ligands, only those 
that can also bind to antigen can undergo TLR-dependent differ-
entiation, thereby focusing the early adaptive (antibody) response 
when specific T-cell help is not yet available or effectively mediating 
antibody response to some T-independent antigens. They outline 
a major T-independent B-cell differentiation pathway, as under-
pinned by dual BCR/TLR induction of AID and CSR, to diversify 
antibody responses. Such a pathway would be evolutionarily con-
served in jawed vertebrates, which express germline encoded and 
nonclonally  distributed  TLRs  and  clonally  distributed  BCRs.  In 
organisms with a primitive adaptive immune system, for example, 
jawless vertebrates, cooperation of TLRs or perhaps other innate 
immune receptors with antigen receptor VLRB58 might have an 
important role in fighting invading pathogens.
Methods
B cells. Single B-cell suspensions were prepared from murine axillary, inguinal and 
cervical lymph nodes using a 70-µm cell strainer. Spleen B cells were resuspended 
in ACK Lysis Buffer (Lonza) to lyse red blood cells, quenched with RPMI contain-
ing 10% FBS (RPMI-FBS) and then resuspended in same medium before further 
B-cell purification. Lymph node and spleen B cells were purified by negative 
depletion of cells expressing CD43, CD4 or Ter-119 using the B cell Isolation kit 
(Miltenyi), following manufacturer’s protocol, resulting in a preparation of more 
than 99% B220 +  sIgδ +  B cells (Supplementary Fig. S10). In most experiments, we 
supplemented the kit with biotinylated mAb to CD11c (clone N418, eBioscience) 
and mAb to IgG1 (clone A85-1, BD Biosciences), thereby achieving an even  
greater degree of sIgδ +  B cell purity.
B-cell-surface analysis and proliferation. sIgδ +  B cells were stimulated for 4 days 
and collected for flow cytometry analysis of surface expression of Ig, B220, CD138 
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Figure 7 | BCR and TLR-induced CSR is impaired in p85–/– B cells. (a) Proportions of sIgG1 +  B cells after stimulation of CFsE-labelled sIgδ +  p85α–/– B 
cells (teal) and their p85α + / +  counterparts (plum) with Pam3CsK4 (100 ng ml − 1), lipid A (1 µg ml − 1), R-848 (30 ng ml − 1) or CpG (1 µM) in the absence 
or presence of anti-δ mAb/dex (100 ng ml − 1), LPs (3 µg ml − 1), all in the presence of IL-4 (3 ng ml − 1), (top panels), and proportions of B cells at each 
cell division that were sIgG1 +  (bottom panels). (b) Proportions of sIgG1 +  B cells after stimulation of CFsE-labelled sIgδ +  p85α–/– B cells (teal) and 
their p85α + / +  counterparts (plum) with mCD154 (1 u ml − 1) plus IL-4 (3 ng ml − 1), in the absence or presence of anti-δ mAb/dex (top panels), and 
proportions of B cells at each cell division that were IgG1 +  (bottom panels). (c) Levels of Aicda, germline Iγ1-Cγ1, circle Iγ1-Cµ and post-recombination 
Iµ-Cγ1 transcripts in p85α–/– B cells (teal) and their p85α + / +  counterparts (plum) stimulated with CpG (1 µM) and anti-δ mAb/dex (100  ng ml − 1), LPs 
(3 µg ml − 1) or mCD154 (1 u ml − 1) in the absence of presence of anti-δ mAb/dex, plus IL-4 (3 ng ml − 1). Data were normalized to the level of Cd79b and are 
depicted as the ratio to the expression levels in p85α + / +  B cells (mean and s.e.m. of data from three independent experiments; P values: t-test).ARTICLE
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or PNA-binding glycoproteins (Supplementary Table S1), as we had described8,11. 
For proliferation studies, B cells were resuspended in PBS at 107 cells per ml and 
incubated with 4 µM of carboxyfluorescein diacetate succinimidyl ester (Invitro-
gen) at 37°C for 5 minutes and immediately quenched with 10 vol of RPMI-FBS.  
Cells were analysed using a BD FACSCalibur (BD Biosciences) and data analysis 
was performed using the FlowJo software (Tree Star). Dead cells (7–AAD + ) were 
excluded from analysis. Cell divisions were determined using the proliferation 
platform of FlowJo.
CSR. sIgδ +  B cells were cultured at 105 cell ml − 1 in RPMI–FBS supplemented with 
50 µM β-mercaptoethanol in the presence of the following stimuli at the indicated 
dose, unless otherwise specified: TLR1/2 ligand Pam3CSK4 (100 ng ml − 1, Invivo-
gen), TLR4 ligand monophophoryl lipid A (lipid A, 1 µg ml − 1, Sigma-Aldrich), 
TLR7 ligand R-848 (30 ng ml − 1, Invivogen) or TLR9 ligand CpG ODN1826 with a 
phosphorothioate backbone (CpG, 1 µM, sequence 5′-TCCATGACGTTCCT 
GACGTT-3′; the sequence of the control GpC ODN 1745 was 5′-TCCATGAG 
CTTCCTGAGTCT-3′; Operon), LPS deproteinized by chloroform extraction 
(3 µg ml − 1, from E. coli, serotype 055:B5, Sigma-Aldrich), mCD154 (1 U ml − 1), 
BAFF (250 ng ml − 1, Alexis) or APRIL (250 ng ml − 1, Alexis). mCD154 was ob-
tained by expression of mouse CD154 on membranes of Sf21 insect cells8. Rat  
anti-mouse δ chain mAb (clone 11-26)-conjugated to dextran18 (anti-δ mAb/dex, 
Fina Biosolutions) was added where indicated. Recombinant IL-4 (3 ng ml − 1) was 
added for CSR to IgG1 and IgE; IFNγ (25 ng ml − 1) for CSR to IgG2a and IgG3 
where indicated; IL-4 (3 ng ml − 1), IL-5 (3 ng ml − 1) and TGFβ (2 ng ml − 1) for CSR 
to IgA (cytokines were all from R&D Systems).
Real-time qRT–PCR transcript analysis. RNA was extracted from 5×106 B cells 
stimulated for 48 h (or as indicated) using the RNeasy Mini Kit (Qiagen). First-strand 
complementary DNA was synthesized from equal amounts of total RNA (4 µg) 
using the SuperScript III System (Invitrogen) and analysed by the SYBR Green dye 
(Bio-Rad) incorporation in PCR reactions involving specific primers (Supplementary 
Table S2) and performed in an iCycler and MyIQ real-time qPCR system (Bio-Rad). 
The levels of transcripts were quantified by the ∆∆CT (cycle threshold) method.
Ca2 +  mobilization assay. For analysis of the elevation of [Ca2 + ]cytosol induced 
by transient BCR-signalling, B cells were loaded with Fluo-3 AM (5 µg ml − 1, 
Invitrogen) and Fura-Red AM (10 µg ml − 1) in 1 ml of RPMI containing 2% (v/v) 
of FBS and 0.04% (v/v) of pluronic F-127 at 37°C for 45 m. After washing with 
HBSS containing 1% (g/v) of BSA, 1 mM of CaCl2 and 1 mM of MgCl2 (HBSS-Ca), 
cells were pelleted and resuspended in 500 µl of HBSS-Ca and stained with APC-
conjugated anti-B220 mAb (eBiosciences). After washing, cells were resuspended 
in HBSS-Ca, stimulated with F(ab′)2 of goat anti-mouse µ chain (anti-µ F(ab′)2, 
Southern Biotech) or anti-δ mAb/dex at indicated concentrations and immediately 
analysed by flow cytometry. The level of free intracellular Ca2 +  was determined by 
the ratio of the Fluo-3 intensity to the Fura-Red intensity using the ‘kinetics’ tool of 
the FlowJo software. For analysis of Ca2 +  mobilization following a long period of 
stimulation, resting B cells were stimulated for 16 h with anti-δ mAb/dex or LPS, or 
nil, lipid A or mCD154 and labelled with Fluo-3 AM and Fura-Red as above, and 
then stimulated with anti-µ F(ab′)2 (5 µg ml − 1) and analysed.
CD79a phosphorylation assay. Spleen B cells (107) were stimulated as indicated, 
collected and resuspended in lysis buffer (20 mM of Tris–Cl, pH 7.5, 150 mM 
of NaCl, 0.5 mM of EDTA, 1% (v/v) of NP-40) supplemented with phosphatase 
inhibitors sodium pyrophosphate (1 mM), NaF (10  mM) and NaVO3 (1 mM) and a 
cocktail of protease inhibitors (Sigma). After sonication and centrifugation, protein 
lysates were pre-cleared with protein A-agarose (Pierce) for 2 h at 4°C and then 
incubated with Armenian hamster anti-mouse CD79a (2 µg ml − 1, BioLegend) or 
control IgGs with irrelevant specificities overnight at 4°C before immunocomplexes 
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were precipitated by protein A-agarose beads. After washing with lysis buffer, pro-
teins were eluted in SDS sample loading buffer and separated by SDS–PAGE. After 
transferring onto nitrocellulose membranes, proteins were subjected to immunob-
lotting involving anti-phosphoCD79a(Tyr182) Ab (Cell Signaling Technology).
NF-B activation assays. Spleen B cells (107) were resuspended in RPMI-FBS and 
stimulated as indicated. Cell lysates were separated by SDS–PAGE and transferred 
onto nitrocellulose membranes. Membranes were subjected to sequential immuno-
blotting with anti-phosphoIκBα or anti-phosphop65 mAb (Cell Signaling Techno-
logy; the canonical NF-κB pathway) or anti-p52 Ab (also detecting p100, Santa 
Cruz; the non-canonical NF-κB pathway). For analysis of the non-canonical  
NF-κB pathway, membranes were stripped in 200 mM of glycine (pH 2.5) at 25 °C 
for 1 h and subjected to immunoblotting involving anti-β-actin mAb (Sigma-
Aldrich). For analysis of the canonical NF-κB pathway, membranes were stripped 
and subjected to immunoblotting involving anti-IκBα or anti-p65 mAb, and 
stripped again for immunoblotting involving anti-β-actin mAb. Signals were  
quantified using the ImageJ software (NIH).
Retroviral transduction. The Aicda coding sequence was cloned into the retroviral 
vector pCSretTAC (pTAC, as we described11), which contains the human IL2RA 
coding sequence (encoding the TAC antigen, CD25), to generate the pTAC–AID 
retroviral vector. Generation of retroviruses in HEK-293 T cells was as we  
described11. For transduction and CSR analysis, mouse B cells were activated by 
CpG in the absence or presence of anti-δ mAb/dex plus IL-4 for 24 h and then 
incubated with virus in the presence of 6 µg ml − 1 polybrene (Sigma-Aldrich) for 
90 m. After culture media were replaced with virus-free media, cells were cultured 
with CpG or anti-δ mAb/dex plus IL-4 for 72 h for sIgG1 expression analysis,  
or for 48 h for transcript analysis, as we described8,11.
Mice and immunization. C57BL/6 mice deficient in p85α (p85α–/–) were gener-
ated after backcrossing of previously described p85α–/– mice in the Balb/c genetic 
background59 onto the C57BL/6 background for 9 generations (Taconic). In these 
mice, mature lymph node B cells were virtually normal in development despite 
defective development of spleen marginal zone B cells38,59. Mice used in all experi-
ments were 8–12 weeks of age and without any apparent infection or disease, and 
were housed in a pathogen-free animal vivarium facility at UC Irvine. All protocols 
were in accordance to the regulations of the UC Irvine IACUC. C57BL/6 mice were 
injected intraperitoneally with 4-hydroxy-3-nitrophenylacetyl (NP) conjugated 
to LPS (NP–LPS) (average: 0.2 NP molecule conjugated with one LPS molecule; 
Biosearch; 25 µg), NP26 (average: 26 NP molecules immobilized on one Ficoll  
molecule; Biosearch; 25 µg) or LPS (25 µg), all in PBS (100 µl) without adjuvant 
and sera were collected before injection and 6 days and 12 days after injection.
Total and NP-specific antibody concentrations. Total IgM, IgG1, IgG2a, IgG3, 
IgA and IgE concentrations in supernatants from B-cell cultures or NP-specific 
IgM, IgG1, IgG2a, IgG2b and IgG3 concentrations in sera of immunized mice  
were determined by specific ELISAs as we reported previously8,11.
Statistical analysis. Statistic analysis was performed by either GraphPad (Prism) 
or Excel (Microsoft) software to determine P values by paired student t-test. 
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